Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9607 posts found.

Amakem appoints new head of CMC and Operations

July 12, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing

Belgium-based Amakem NV has announced the appointment of Maarten van Geffen as head of CMC and Operations. The kinase platform …
Appointment
Janssen image

Janssen buys into regenerative diabetes portfolio

July 11, 2012 Research and Development, Sales and Marketing CureBeta, Evotec, Janssen, diabetes

Janssen has licensed a portfolio of drugs designed to regenerate insulin-producing beta cells. Janssen will receive exclusive access to a …
News

Blow for BioInvent as vascular treatment fails

July 11, 2012 Research and Development, Sales and Marketing BI-204, BioInvent, LDL, Sweden

Swedish biotech company BioInvent has suffered a new blow with the failure of its lead pipeline candidate.  The company’s share …
News

Significant reorganisation for Chelsea Therapeutics

July 11, 2012 Research and Development, Sales and Marketing Chelsea Therapeutics, Northera, biopharma, biotech

Biopharma development firm Chelsea Therapeutics has announced a major corporate reorganisation. The move includes a significant reduction in headcount, the …
News

New chief executive for Daiichi Sankyo Europe

July 10, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Daiichi Sankyo

Jan Van Ruymbeke has been appointed as the new chief executive of Daiichi Sankyo Europe from October. Van Ruymbeke, from Belgium, …
Appointment

R&D, East & West: Lilly invests in its global research network

July 10, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Asia, China, R&D, diabetes, lilly

Eli Lilly officially opened its new research facilities at its R&D base in Erl Wood in Surrey in April. The …
Feature
Xarelto image

Priority review for Xarelto’s new indications

July 10, 2012 Manufacturing and Production, Research and Development, Sales and Marketing Bayer, Boehringer, Eliquis, FDA, Janssen, Pradaxa, Xarelto

Xarelto is to be given a FDA fast-track review for a range of anti-blood clotting uses. Xarelto (rivaroxaban) gained its …
News
louferrari

Savient appoints new president and chief executive

July 10, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Ferrari, Savient, cuts

Savient Pharmaceuticals has appointed Louis Ferrari to the role of president and chief executive for the firm. Ferrari succeeds Savient’s …
Appointment

Shionogi opens UK office

July 9, 2012 Research and Development, Sales and Marketing Crestor, Japan, Osaka, Shionogi, cholesterol

Japanese pharma firm Shionogi & Co has opened a new office in London and pledged to expand into Europe. Osaka-based …
News

Boehringer collaborates with Havard

July 9, 2012 Research and Development, Sales and Marketing Boehringer, Havard, oncology, research deal

Boehringer Ingelheim has established a translational research collaboration with the presidents and fellows of Harvard College. The aim of the …
News

The problem with medical publishing

July 6, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Les Rose, MMR, medical publishing

I’ve often said that however bad one’s research, it’s possible to get it published somewhere. I have been thinking about …
Feature

More job cuts planned at Sanofi, says union

July 6, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Genzyme, Sanofi, Viehbacher, cuts

Sanofi has confirmed that it is considering a restructuring of its operations in France, but has refused to comment on …
News
erbitux image

Erbitux fails in gastric cancer trial

July 6, 2012 Research and Development, Sales and Marketing Erbitux, Merck Serono, Roche, failure, gastric cancer

Merck’s Erbitux has failed to increase survival in patients with gastric cancer, representing a blow to the firm’s ambition to …
News
joachim_hasenmaier

Boehringer Ingelheim makes changes to board

July 5, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Boehringer Ingelheim

Boehringer Ingelheim has appointed Dr Joachim Hasenmaier to its board of managing directors. The 52-year-old will take over responsibility for …
Appointment
screen_shot_2012-07-05_at_11

New chairman of the board for Dendreon

July 5, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Dendreon, Provenge, johnson, prostate cancer

Dendreon has announced that its president and chief executive John Johnson has assumed the additional title of chairman of the …
Appointment
The Gateway to Local Adoption Series

Latest content

Stage4You encourages stage 4 bowel cancer patients to prioritise mental health ahead of Bowel Cancer Awareness Month

March 26, 2026

Scotland starts newborn screening for SMA

March 26, 2026

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026